LeonaBio, Inc. Accumulated Other Comprehensive Income
LeonaBio, Inc. (LONA) had Accumulated Other Comprehensive Income of -$9.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-14
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$9.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$13.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$4.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$9.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | -$13.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | -$4.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | -$2.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | -$3.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | -$4.00K 10-Q · filed 2025-05-09 |
| 2024-12-31 | $1.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $3.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$38.00K 10-Q · filed 2024-08-01 |
| 2024-03-31 | -$137.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | -$349.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | -$678.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$939.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | -$1.03M 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$1.96M 10-K · filed 2024-02-22 |
| 2022-09-30 | -$2.47M 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$1.93M 10-Q · filed 2022-08-15 |
| 2022-03-31 | -$1.46M 10-Q · filed 2022-05-12 |
| 2021-12-31 | -$388.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | $4.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $37.00K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $28.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $33.00K 10-K · filed 2022-03-28 |
| 2020-09-30 | $7.00K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |